1991
DOI: 10.1016/0092-8674(91)90283-5
|View full text |Cite
|
Sign up to set email alerts
|

Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

33
1,216
4
23

Year Published

1993
1993
2014
2014

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,866 publications
(1,276 citation statements)
references
References 20 publications
33
1,216
4
23
Order By: Relevance
“…In animal species extensive variation of trinucleotide repeats in coding sequences has also been observed (Edwards et a/., 1991), and expansion of trinucleotide microsatellites within coding sequences in humans has been shown to be linked with major genetic disease, such as Kennedy's disease (La Spada eta/., 1991), fragile X syndrome (Fu et a/., 1991) and myotonic dystrophy (Brook eta/., 1992).…”
Section: Discussionmentioning
confidence: 99%
“…In animal species extensive variation of trinucleotide repeats in coding sequences has also been observed (Edwards et a/., 1991), and expansion of trinucleotide microsatellites within coding sequences in humans has been shown to be linked with major genetic disease, such as Kennedy's disease (La Spada eta/., 1991), fragile X syndrome (Fu et a/., 1991) and myotonic dystrophy (Brook eta/., 1992).…”
Section: Discussionmentioning
confidence: 99%
“…19 The reaction product was analysed on an ABI310 (Applied Biosystems, Foster City, CA, USA). Data generation and evaluation have been performed in different centres following similar procedures.…”
Section: Molecular Analysismentioning
confidence: 99%
“…(25) The length of CGG repeat in the 5 0 UTR of fragile X mental retardation gene (FMR1) is also tightly correlated with methylation of the promoter and hence transcription of the gene. (26) Apart from epigenetic regulation, the number of genetic lesions and nature of functional domain altered by mutation or polymorphism may contribute to phenotypic variability in complex diseases.…”
Section: Molecular Basis Of Ip-vementioning
confidence: 99%